Tuhura Biosciences Stock Alpha and Beta Analysis
| HURA Stock | 4.48 0.48 12.00% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as TuHURA Biosciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in TuHURA Biosciences over a specified time horizon. Remember, high TuHURA Biosciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to TuHURA Biosciences' market risk premium analysis include:
Beta 3.52 | Alpha (0.05) | Risk 11.15 | Sharpe Ratio 0.0184 | Expected Return 0.2 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
TuHURA |
TuHURA Biosciences Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. TuHURA Biosciences market risk premium is the additional return an investor will receive from holding TuHURA Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in TuHURA Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate TuHURA Biosciences' performance over market.| α | -0.05 | β | 3.52 |
TuHURA Biosciences expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of TuHURA Biosciences' Buy-and-hold return. Our buy-and-hold chart shows how TuHURA Biosciences performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.TuHURA Biosciences Market Price Analysis
Market price analysis indicators help investors to evaluate how TuHURA Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading TuHURA Biosciences shares will generate the highest return on investment. By understating and applying TuHURA Biosciences stock market price indicators, traders can identify TuHURA Biosciences position entry and exit signals to maximize returns.
TuHURA Biosciences Return and Market Media
The median price of TuHURA Biosciences for the period between Mon, Sep 23, 2024 and Sun, Dec 22, 2024 is 5.56 with a coefficient of variation of 21.14. The daily time series for the period is distributed with a sample standard deviation of 1.17, arithmetic mean of 5.53, and mean deviation of 0.94. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Amphastar Pharm Shows Rising Relative Strength Still Shy Of Key Benchmark | 10/17/2024 |
2 | Amphastar Pharm Earns Relative Strength Rating Upgrade | 10/29/2024 |
3 | Revenues Not Telling The Story For Kyung Nam Pharm Co.,Ltd. After Shares Rise 29 | 11/11/2024 |
4 | Acquisition by Dearborn Dan of 489848 shares of TuHURA Biosciences at 4.94 subject to Rule 16b-3 | 11/12/2024 |
5 | High Tech Pharm Third Quarter 2024 Earnings EPS 223 | 11/14/2024 |
6 | Risks To Shareholder Returns Are Elevated At These Prices For Hanmi Pharm. Co., Ltd. | 11/19/2024 |
7 | TuHURA Biosciences, Inc. Outlines Development Pathway for Single Phase 3 Accelerated Approval Registration Trial in First Line Treatment of Advanced or Metastat... | 11/25/2024 |
8 | Hainan Poly Pharm Is Making Moderate Use Of Debt | 12/02/2024 |
9 | Korea drops Hyundai Pharms abortion pill review amid delay in legislation | 12/11/2024 |
10 | HURA Stock Alert Halper Sadeh LLC Is Investigating Whether the Merger of TuHURA Biosciences, Inc. Is Fair to Shareholders | 12/12/2024 |
11 | Is High Tech Pharm Co., Ltd.s Stocks Recent Performance Being Led By Its Attractive Financial Prospects | 12/16/2024 |
12 | TuHURA Biosciences Now Covered by Rodman Renshaw | 12/20/2024 |
About TuHURA Biosciences Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including TuHURA or other stocks. Alpha measures the amount that position in TuHURA Biosciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Net Debt To EBITDA | 0.0453 | 0.0431 | Intangibles To Total Assets | 0.003436 | 0.004885 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards TuHURA Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, TuHURA Biosciences' short interest history, or implied volatility extrapolated from TuHURA Biosciences options trading.
Build Portfolio with TuHURA Biosciences
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out TuHURA Biosciences Backtesting, TuHURA Biosciences Valuation, TuHURA Biosciences Correlation, TuHURA Biosciences Hype Analysis, TuHURA Biosciences Volatility, TuHURA Biosciences History and analyze TuHURA Biosciences Performance. For information on how to trade TuHURA Stock refer to our How to Trade TuHURA Stock guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
TuHURA Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.